Enter your terms above and click the 'Search' button.

Showing articles 0 to 9 of 9 Filter Applied: myasthenic syndrome (Click to remove) Evidence-based Guideline: Intravenous Immunoglobulin in the Treatment of Neuromascular Disorders Neurol 78:1009-1015, Patwa,H.S.,et al, 2012 The use of rituximab in myasthenia gravis and Lambert--Eaton myasthenic syndrome JNNP 82:671-673, Maddison, P.,et al, 2011 Statin-Associated Myasthenia Gravis Medicine 85:82-85, Purvin,V.,et al, 2006 Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases JAMA 291:2367-2375, Dalakas,M.C., 2004 Intravenous Immunoglobulin Treatment in Neurologic Disorders Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999 Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified? Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999 Intravenous Immunoglobulin in the Treatment of Autoimmune Neuromuscular Diseases:Present Status and Practical Therapeutic Guidelines Muscle & Nerve 22:1479-1497, Dalakas,M.C., 1999 Drugs and Myasthenia Gravis, An Update Arch Int Med 157:399-408, Wittbrodt,E.T., 1997 Adverse Drug Effects on Neuromuscular Transmission Semin Neurol 10:89-102, Howard,J.F., 1990 Showing articles 0 to 9 of 9